Literature DB >> 15534042

5-HT1A receptors, gene repression, and depression: guilt by association.

Paul R Albert1, Sylvie Lemonde.   

Abstract

The serotonin system is implicated in major depression and suicide and is negatively regulated by somatodendritic 5-HT1A autoreceptors. Desensitization of 5-HT1A autoreceptors is implicated in the 2- to 3-week latency for antidepressant treatments. Alterations in 5-HT1A receptor levels are reported in depression and suicide, and gene knockout of the 5-HT1A receptor results in an anxiety phenotype, suggesting that abnormal transcriptional regulation of this receptor gene may underlie these disorders. The 5-HT1A receptor gene is negatively regulated in neurons by repressors including REST/NRSF, Freud-1, NUDR/Deaf-1, and Hes5. The association with major depression, suicide, and panic disorder of a new functional 5-HT1A polymorphism at C(-1019)G that selectively blocks repression of the 5-HT1A autoreceptor by NUDR further suggests a causative role for altered regulation of this receptor in predisposition to mental illness. The authors review evidence that altered transcription of the 5-HT1A receptor can affect the serotonin system and limbic and cortical areas, leading to predisposition to depression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15534042     DOI: 10.1177/1073858404267382

Source DB:  PubMed          Journal:  Neuroscientist        ISSN: 1073-8584            Impact factor:   7.519


  94 in total

Review 1.  Increased expression of the anti-apoptotic protein Bcl-xL in the brain is associated with resilience to stress-induced depression-like behavior.

Authors:  Nikolay N Dygalo; Tatyana S Kalinina; Veta V Bulygina; Galina T Shishkina
Journal:  Cell Mol Neurobiol       Date:  2012-01-26       Impact factor: 5.046

2.  Traumatic brain injury-induced cognitive and histological deficits are attenuated by delayed and chronic treatment with the 5-HT1A-receptor agonist buspirone.

Authors:  Adam S Olsen; Christopher N Sozda; Jeffrey P Cheng; Ann N Hoffman; Anthony E Kline
Journal:  J Neurotrauma       Date:  2012-04-23       Impact factor: 5.269

Review 3.  Pharmacogenetics of antidepressant response.

Authors:  Stefano Porcelli; Antonio Drago; Chiara Fabbri; Sara Gibiino; Raffaella Calati; Alessandro Serretti
Journal:  J Psychiatry Neurosci       Date:  2011-03       Impact factor: 6.186

4.  Region-specific regulation of 5-HT1A receptor expression by Pet-1-dependent mechanisms in vivo.

Authors:  Kirsten X Jacobsen; Margaret Czesak; Mariam Deria; Brice Le François; Paul R Albert
Journal:  J Neurochem       Date:  2011-01-24       Impact factor: 5.372

Review 5.  5-HT(1A) receptor function in major depressive disorder.

Authors:  Jonathan Savitz; Irwin Lucki; Wayne C Drevets
Journal:  Prog Neurobiol       Date:  2009-02-07       Impact factor: 11.685

6.  Human Freud-2/CC2D1B: a novel repressor of postsynaptic serotonin-1A receptor expression.

Authors:  Mahmoud R Hadjighassem; Mark C Austin; Bernadeta Szewczyk; Mireille Daigle; Craig A Stockmeier; Paul R Albert
Journal:  Biol Psychiatry       Date:  2009-05-07       Impact factor: 13.382

Review 7.  Drugs, biogenic amine targets and the developing brain.

Authors:  Aliya L Frederick; Gregg D Stanwood
Journal:  Dev Neurosci       Date:  2009-04-17       Impact factor: 2.984

Review 8.  Genetic approaches for understanding the role of serotonin receptors in mood and behavior.

Authors:  Zoe R Donaldson; Katherine M Nautiyal; Susanne E Ahmari; René Hen
Journal:  Curr Opin Neurobiol       Date:  2013-02-04       Impact factor: 6.627

9.  Assessment of human serotonin 1A receptor polymorphisms and SSRI responsiveness.

Authors:  Gary M Levin; Toya M Bowles; Megan J Ehret; Taimour Langaee; Jennifer Y Tan; Julie A Johnson; William J Millard
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

10.  Gender-specific decrease in NUDR and 5-HT1A receptor proteins in the prefrontal cortex of subjects with major depressive disorder.

Authors:  Bernadeta Szewczyk; Paul R Albert; Ariel M Burns; Margaret Czesak; James C Overholser; George J Jurjus; Herbert Y Meltzer; Lisa C Konick; Lesa Dieter; Nicole Herbst; Warren May; Grazyna Rajkowska; Craig A Stockmeier; Mark C Austin
Journal:  Int J Neuropsychopharmacol       Date:  2008-06-19       Impact factor: 5.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.